These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Clinical and histopathological risk factors to predict sentinel lymph node positivity, disease-free and overall survival in clinical stages I-II AJCC skin melanoma: outcome analysis from a single-institution prospectively collected database. Mandalà M; Imberti GL; Piazzalunga D; Belfiglio M; Labianca R; Barberis M; Marchesi L; Poletti P; Bonomi L; Novellino L; Di Biagio K; Milesi A; Guerra U; Tondini C Eur J Cancer; 2009 Sep; 45(14):2537-45. PubMed ID: 19553103 [TBL] [Abstract][Full Text] [Related]
3. Regression does not predict nodal metastasis or survival in patients with cutaneous melanoma. Burton AL; Gilbert J; Farmer RW; Stromberg AJ; Hagendoorn L; Ross MI; Martin RC; McMasters KM; Scoggins CR; Callender GG Am Surg; 2011 Aug; 77(8):1009-13. PubMed ID: 21944515 [TBL] [Abstract][Full Text] [Related]
4. Sentinel node biopsy should be offered in thin melanoma with mitotic rate greater than one. Sekula-Gibbs SA; Shearer MA Dermatol Surg; 2011 Aug; 37(8):1080-8. PubMed ID: 21635622 [TBL] [Abstract][Full Text] [Related]
5. Diversity of stage III melanoma in the era of sentinel lymph node biopsy. Egger ME; Callender GG; McMasters KM; Ross MI; Martin RC; Edwards MJ; Urist MM; Noyes RD; Sussman JJ; Reintgen DS; Stromberg AJ; Scoggins CR Ann Surg Oncol; 2013 Mar; 20(3):956-63. PubMed ID: 23064795 [TBL] [Abstract][Full Text] [Related]
6. Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas. Cherpelis BS; Haddad F; Messina J; Cantor AB; Fitzmorris K; Reintgen DS; Fenske NA; Glass LF J Am Acad Dermatol; 2001 May; 44(5):762-6. PubMed ID: 11312421 [TBL] [Abstract][Full Text] [Related]
7. Mitotic rate in cutaneous melanomas ≤1 mm in thickness: a prospective study. Litzner BR; Etufugh CN; Stepenaskie S; Hynan LS; Cockerell CJ Am J Dermatopathol; 2012 Dec; 34(8):827-32. PubMed ID: 22878366 [TBL] [Abstract][Full Text] [Related]
8. Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma. Azimi F; Scolyer RA; Rumcheva P; Moncrieff M; Murali R; McCarthy SW; Saw RP; Thompson JF J Clin Oncol; 2012 Jul; 30(21):2678-83. PubMed ID: 22711850 [TBL] [Abstract][Full Text] [Related]
9. The sentinel lymph node status is an important factor for predicting clinical outcome in patients with Stage I or II cutaneous melanoma. Statius Muller MG; van Leeuwen PA; de Lange-De Klerk ES; van Diest PJ; Pijpers R; Ferwerda CC; Vuylsteke RJ; Meijer S Cancer; 2001 Jun; 91(12):2401-8. PubMed ID: 11413531 [TBL] [Abstract][Full Text] [Related]
10. Should all patients with melanoma between 1 and 2 mm Breslow thickness undergo sentinel lymph node biopsy? Mays MP; Martin RC; Burton A; Ginter B; Edwards MJ; Reintgen DS; Ross MI; Urist MM; Stromberg AJ; McMasters KM; Scoggins CR Cancer; 2010 Mar; 116(6):1535-44. PubMed ID: 20108306 [TBL] [Abstract][Full Text] [Related]
16. The impact of factors beyond Breslow depth on predicting sentinel lymph node positivity in melanoma. Paek SC; Griffith KA; Johnson TM; Sondak VK; Wong SL; Chang AE; Cimmino VM; Lowe L; Bradford CR; Rees RS; Sabel MS Cancer; 2007 Jan; 109(1):100-8. PubMed ID: 17146784 [TBL] [Abstract][Full Text] [Related]
17. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma. Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039 [TBL] [Abstract][Full Text] [Related]
18. Tumor-infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma. Taylor RC; Patel A; Panageas KS; Busam KJ; Brady MS J Clin Oncol; 2007 Mar; 25(7):869-75. PubMed ID: 17327608 [TBL] [Abstract][Full Text] [Related]
19. Clinical and pathologic factors associated with distant metastasis and survival in patients with thin primary cutaneous melanoma. Murali R; Haydu LE; Long GV; Quinn MJ; Saw RP; Shannon K; Spillane AJ; Stretch JR; Kefford RF; Thompson JF; Scolyer RA Ann Surg Oncol; 2012 Jun; 19(6):1782-9. PubMed ID: 22350600 [TBL] [Abstract][Full Text] [Related]
20. A novel and accurate computer model of melanoma prognosis for patients staged by sentinel lymph node biopsy: comparison with the American Joint Committee on Cancer model. Callender GG; Gershenwald JE; Egger ME; Scoggins CR; Martin RC; Schacherer CW; Edwards MJ; Urist MM; Ross MI; Stromberg AJ; McMasters KM J Am Coll Surg; 2012 Apr; 214(4):608-17; discussion 617-9. PubMed ID: 22342785 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]